MGI Pharma News
Most Popular MGI Pharma Story
Eisai inks $255M deal to buy AkaRx
New Jersey-based AkaRx is getting bought out for $255 million by Japan's Eisai, which picked up the option to buy the developer when it scooped up MGI Pharma in a $3.9 billion buyout almost two years Read more...
Latest Headlines
- December 18, 2009
- July 28, 2008
- December 10, 2007
- November 29, 2007
- August 30, 2007
- August 29, 2007
- December 13, 2006
- October 12, 2006
- August 9, 2006
- August 8, 2006
- August 8, 2006
- July 19, 2006
- July 5, 2006
- May 30, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
